SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-244473
Filing Date
2019-09-13
Accepted
2019-09-13 08:27:55
Documents
4
Period of Report
2019-09-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d804462d8k.htm 8-K 16847
2 EX-99.1 d804462dex991.htm EX-99.1 8161
3 GRAPHIC g804462g0913045653479.jpg GRAPHIC 631
4 GRAPHIC g804462g0913045653760.jpg GRAPHIC 3890
  Complete submission text file 0001193125-19-244473.txt   32917
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 191091574
SIC: 2834 Pharmaceutical Preparations